(Q43216546)

16 November 2017

title

Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats (English)

1 reference

16 November 2017

Maya Sakurada

1

1 reference

16 November 2017

Takanobu Yoshimoto

2

1 reference

16 November 2017

Naoko Sekizawa

3

1 reference

16 November 2017

Yuki Hirono

4

1 reference

16 November 2017

Noriko Suzuki

5

1 reference

16 November 2017

Yukio Hirata

6

1 reference

16 November 2017

publication date

18 December 2009

1 reference

16 November 2017

published in

Hypertension Research

1 reference

16 November 2017

volume

33

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

229-235

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.211

16 November 2017

exact match

0 references

cites work

Aldosterone, mineralocorticoid receptors and vascular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone as a cardiovascular risk hormone

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone induces superoxide generation via Rac1 activation in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Cilostazol as a Unique Antithrombotic Agent

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDL

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone Increases NHE-1 Expression and Induces NHE-1-Dependent Hypertrophy in Neonatal Rat Ventricular Myocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

SGK1: aldosterone-induced relay of Na+ transport regulation in distal kidney nephron cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

The pathophysiology of aldosterone in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone induces a vascular inflammatory phenotype in the rat heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

PDGF and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aldosterone increases osteopontin gene expression in rat endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Vascular NAD(P)H oxidases: specific features, expression, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Changes in platelet function due to hypertension: comparison of experimental hypertension with spontaneous hypertension in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.211

7 January 2021

Identifiers

DOI

10.1038/HR.2009.211

1 reference

16 November 2017

1 reference